Erik Sturegård
1 – 20 of 55
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Pregnancy Outcomes in Women Screened for Tuberculosis Infection in Swedish Antenatal Care
(
- Contribution to journal › Article
- 2023
-
Mark
Mechanisms of a Mycobacterium tuberculosis Active Peptide
(
- Contribution to journal › Article
- 2022
-
Mark
Tuberculosis infection and stillbirth in Ethiopia —A prospective cohort study
(
- Contribution to journal › Article
-
Mark
Dynamics of Mycobacterium tuberculosis-Specific and Nonspecific Immune Responses in Women with Tuberculosis Infection during Pregnancy
(
- Contribution to journal › Article
- 2021
-
Mark
A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy
(
- Contribution to journal › Article
-
Mark
The Impact of Borderline Quantiferon-TB Gold Plus Results for Latent Tuberculosis Screening under Routine Conditions in a Low-Endemicity Setting
(
- Contribution to journal › Article
-
Mark
Tuberculosis Infection in Women of Reproductive Age : A Cross-sectional Study at Antenatal Care Clinics in an Ethiopian City
(
- Contribution to journal › Article
-
Mark
Longitudinal Mycobacterium tuberculosis-specific Interferon Gamma responses in Ethiopian HIV-negative women during pregnancy and postpartum
(
- Contribution to journal › Article
- 2020
-
Mark
Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results
(
- Contribution to journal › Article
- 2019
-
Mark
Transmission dynamics study of tuberculosis isolates with whole genome sequencing in southern Sweden
(
- Contribution to journal › Article
- 2018
-
Mark
Performance of QuantiFERON-TB gold plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting
(
- Contribution to journal › Article
-
Mark
Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”
(
- Contribution to journal › Letter
-
Mark
A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis
(
- Contribution to journal › Article
-
Mark
What is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi-and extensively drug-resistant tuberculosis
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term Outcome of Antiretroviral Treatment in Patients With and Without Concomitant Tuberculosis Receiving Health Center-Based Care-Results From a Prospective Cohort Study
(
- Contribution to journal › Article
-
Mark
A borderline range for Quantiferon Gold In-Tube results
(
- Contribution to journal › Article
- 2016
-
Mark
Factors associated with early mortality in HIV-positive men and women investigated for tuberculosis at Ethiopian health centers
(
- Contribution to journal › Article
-
Mark
ESX-1 exploits type I IFN-signalling to promote a regulatory macrophage phenotype refractory to IFNγ-mediated autophagy and growth restriction of intracellular mycobacteria
(
- Contribution to journal › Article
- 2015
-
Mark
Plasma Levels of Neopterin and C-Reactive Protein (CRP) in Tuberculosis (TB) with and without HIV Coinfection in Relation to CD4 Cell Count.
(
- Contribution to journal › Article
-
Mark
Impaired CXCR1-dependent oxidative defence in active tuberculosis patients.
(
- Contribution to journal › Article